Cargando…

ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies

Thrombotic microangiopathies (TMAs) comprise a group of distinct disorders characterized by microangiopathic hemolytic anemia, thrombocytopenia, and microvascular thrombosis. For many years distinction between these TMAs, especially between thrombotic thrombocytopenic purpura (TTP) and hemolytic ure...

Descripción completa

Detalles Bibliográficos
Autor principal:	Sarig, Galit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rambam Health Care Campus 2014
Materias:	Discoveries from the Bench to the Bedside
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222415/ https://www.ncbi.nlm.nih.gov/pubmed/25386342 http://dx.doi.org/10.5041/RMMJ.10160

Ejemplares similares

Dendritic Cell Cancer Vaccines: From the Bench to the Bedside
por: Katz, Tamar, et al.
Publicado: (2014)

Genetic Stratification in Myeloid Diseases: From Risk Assessment to Clinical Decision Support Tool
por: Ofran, Yishai
Publicado: (2014)

Minimal Residual Disease Surveillance in Chronic Lymphocytic Leukemia by Fluorescence-Activated Cell Sorting
por: Ringelstein-Harlev, Shimrit, et al.
Publicado: (2014)

Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson’s Disease with Neuroprotective Potential
por: Finberg, John P.M.
Publicado: (2010)

Impact of Heparanase and the Tumor Microenvironment on Cancer Metastasis and Angiogenesis: Basic Aspects and Clinical Applications
por: Vlodavsky, Israel, et al.
Publicado: (2011)

Stem Cells for Diabetes Complications: A Future Potential Cure
por: Khamaisi, Mogher, et al.
Publicado: (2017)

Endovascular interventions for central vein stenosis
por: Agarwal, Anil K.
Publicado: (2015)

Current progress in ABO-incompatible kidney transplantation
por: Koo, Tai Yeon, et al.
Publicado: (2015)

RNA sequencing of the nephron transcriptome: a technical note
por: Lee, Jae Wook
Publicado: (2015)

Organ-on-a-chip and the kidney
por: Kim, Sejoong, et al.
Publicado: (2015)

Neuro-tracing approach to study kidney innervation: a technical note
por: Lee, Sanghee, et al.
Publicado: (2017)

Messenger RNA vaccines against SARS-CoV-2
por: Topol, Eric J.
Publicado: (2021)

JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis
por: Choi, Michael Y., et al.
Publicado: (2018)

Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: A case report
por: Capalbo, Carlo, et al.
Publicado: (2014)

Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?
por: Graziano, Vincenzo, et al.
Publicado: (2015)

Therapeutic approach guided by genetic alteration: Use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression
por: Lipkin, Jacob S, et al.
Publicado: (2015)

Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy
por: Wyluda, Edward J, et al.
Publicado: (2015)

Metformin: a modulator of bevacizumab activity in cancer? A case report
por: Indraccolo, Stefano, et al.
Publicado: (2015)

Bortezomib-related neuropathy may mask CNS relapse in multiple myeloma: A call for diligence
por: Abid, Muhammad Bilal, et al.
Publicado: (2016)

How breast cancer chemotherapy increases the risk of leukemia: Thoughts about a case of diffuse large B-cell lymphoma and leukemia after breast cancer chemotherapy
por: Zhang, Bin, et al.
Publicado: (2016)

A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach
por: Caggiari, Laura, et al.
Publicado: (2017)

Effective treatment of aggressive fibromatosis with celecoxib guided by genetic testing
por: Yang, Shanshan, et al.
Publicado: (2017)

HIF2A germline–mutation-induced polycythemia in a patient with VHL-associated renal-cell carcinoma
por: Liu, Qiuli, et al.
Publicado: (2017)

A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy
por: Liu, Qiuli, et al.
Publicado: (2018)

CMTR1-ALK: an ALK fusion in a patient with no response to ALK inhibitor crizotinib
por: Du, Xue, et al.
Publicado: (2018)

A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib
por: Zhu, You-cai, et al.
Publicado: (2018)

Successful treatment using apatinib in intractable brain edema: A case report and literatures review
por: Song, Yanqiu, et al.
Publicado: (2018)

Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer
por: Tsoli, Maria, et al.
Publicado: (2018)

Next-generation sequencing reveals mutational accordance between cell-free DNA from plasma, malignant pleural effusion and ascites and directs targeted therapy in a gastric cancer patient
por: Zhou, Shujuan, et al.
Publicado: (2018)

Pancreatic acinar cell carcinoma is associated with BRCA2 germline mutations: a case report and literature review
por: Kryklyva, Valentyna, et al.
Publicado: (2019)

Ototoxicity in patients with invasive ductal breast cancer who were treated with docetaxel: report of two cases
por: Xuan, Liang, et al.
Publicado: (2020)

Unexpected favorable outcome to etoposide and cisplatin in a small cell lung cancer transformed patient: a case report
por: Xie, Zhanhong, et al.
Publicado: (2019)

De novo MET amplification promotes intrinsic resistance to first-generation EGFR tyrosine kinase inhibitors
por: Li, Jing-Wen, et al.
Publicado: (2019)

Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss
por: Frisone, Daniele, et al.
Publicado: (2019)

Nivolumab induced hyperprogressive disease in advanced esophageal squamous cell carcinoma
por: Sun, Dantong, et al.
Publicado: (2020)

Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib
por: Deland, Lily, et al.
Publicado: (2021)

Partial treatment response to capmatinib in MET-amplified metastatic intrahepatic cholangiocarcinoma: case report & review of literature
por: Lefler, Daniel S, et al.
Publicado: (2022)

Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid
por: Kim, Hichul, et al.
Publicado: (2022)

Dramatic response to local radiotherapy in a refractory metastatic mediastinal yolk sac tumor patient harboring a germline BRCA2 frameshift mutation: a case report
por: Cheng, Xi, et al.
Publicado: (2022)

Hormonal Management of Small Bowel Failure
por: Patel, Kumkum S, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_noraml9slgg8d1s9k1mgbqqbv3